In addition to symptom reduction, treatment includes supporting sustained daily functioning and overall wellness as part of comprehensive ulcerative colitis care
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
The cyanocobalamin component of the injection may interact with certain medications that affect vitamin B12 absorption or metabolism
Some clinics may offer it as a nasal spray or troche, though injection remains the most effective delivery method
However, further studies are still needed to optimize its clinical application, including dosage form improvement, combination therapy strategies and long-term safety assessment
Research in humans shows that Retatrutide activates all three incretin receptors: GIP, GLP-1, and GCG, to their full extent